Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology)

List of Tables

The global Biomaterials market is projected to reach USD 68.93 billion by 2030 from USD 48.36 billion in 2025, at CAGR of 7.3% from 2025 to 2030.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	By Type, By Application
Regions covered	North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa

The expansion of the Global Biomaterials market has been fueled by the advancements in healthcare facilities and systems, and the rising advancements in smart, biocompatible, and 3D-printed biomaterials.

In 2024, The metallic biomaterials held the highest share in the Global Biomaterials market by type.

The market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials. The highest share by type was of metallic biomaterials due to their wide application in orthopedic, dental, and cardiovascular fields. The mechanical properties make them the suitable for application in implants such as joint replacements, fracture fixation devices, dental implants, and stints. The commonly used biomaterials are titanium and its alloys, stainless steel, cobalt chromoly alloys, and more recently, biodegradable metal alloys like magnesium-based metal. These exhibit remarkable resistance to fatigue failure, corrosion, and remarkable compatibility. They were also found to be safe for long-term use in a physiological environment. However, constant progress in surface modification technologies such as surface modification through coating and surface treatment has greatly improved their osseointegration, friction, and resistance to infections. Moreover, rising surgical procedures, an ageing population, and an increase in musculoskeletal and cardiac disorders are expected to propel the demand for metallic biomaterials across the globe, consolidating their strong position in the global biomaterials.

"Joint replacement segment reported for the highest share of the orthopedic application segment in 2024."

Within the application segment, the Global Biomaterials market is divided into Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Tissue engineering, neurological application Wound Healing, Urinary application, and Other Applications. In 2024, Joint replacement represents the leading segment in orthopedic applications in the global biomaterials. Due to an increasing number of people suffering from degenerative joint diseases like osteoarthritis and rheumatoid arthritis. factors like an aging population, and an increasing rate of obesity have also led to an increasing number of people undergoing knee, shoulder, or hip replacements. However, materials used in joint replacements, have improved strength, durability, or biocompatibility that makes these materials highly suitable for applications involving heavy loading. Advances in implant design, surface technology, or method of implantation also continue to increase patient survival with these implants. Furthermore, increasing utilization of minimal invasiveness in surgeries, increasing availability of orthopedic care in developing nations, or ever-improving implant technologies continue to drive this market.

APAC accounted for the fastest growing market share in the global Biomaterials market from 2025 to 2030.

The biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. APAC region is projected to grow at the highest CAGR during the forecast period . This surge is driven by rapid healthcare infrastructure expansion in China, India, and Japan, alongside booming medical tourism and rising chronic disease burdens like orthopedics and cardiology. An aging population, government R&D investments, and adoption of 3D-printed implants and bioresorbable polymers fuel demand for advanced metallic, polymeric, and ceramic solutions in joint replacements, stents, and tissue engineering. Local manufacturing hubs and regulatory streamlining further accelerate market penetration, positioning APAC as a key innovation powerhouse.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side-70% and Demand Side-30%
By Designation: Managers-45%, CXO and Directors-30%, and Executives-25%
By Region: North America-40%, Europe-25%, the Asia Pacific-25%, Latin America-5%, and the Middle East & Africa-5%

List of Key Companies Profiled in the Report:

Key players in the Global Biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc. (US), and GELITA AG (Germany).

Research Coverage:

This research report categorizes the Global Biomaterials market, By Type: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials, By Application: Cardiovascular Orthopaedic, Dental, Plastic Surgery, Urinary, Wound Healing, Tissue Engineering, Ophthalmology, Neurological/Central Nervous System, Other Applications. and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Biomaterials market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the Global Biomaterials market.

Key Benefits of Buying the Report:

The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall Biomaterials market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Rising advancements in smart, biocompatible, and 3D-printed biomaterials, Advancements in healthcare facilities and systems), restraints (High development and production costs associated with advanced biomaterials.), opportunities (Expanding applications in tissue engineering and regenerative medicine.) and Challenges (Concerns related to biocompatibility, safety, and adverse immune responses).
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the Global Biomaterials market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Global Biomaterials market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the Global Biomaterials market.

Product Code: BT 1556

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION
- 1.3.2 REGIONAL SCOPE
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING BIOMATERIALS MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 BIOMATERIALS MARKET OVERVIEW
3.2 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE AND COUNTRY, 2025
3.3 BIOMATERIALS MARKET: GEOGRAPHIC SNAPSHOT

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
  - 4.2.1.1 Rising advancements in smart, biocompatible, and 3D printed biomaterials
  - 4.2.1.2 Advancements in healthcare systems, physical infrastructure, and reimbursement frameworks
  - 4.2.1.3 Growing demand for biomaterials in wound healing and plastic surgery
  - 4.2.1.4 Increasing use of biomaterials in multiple therapeutic areas
- 4.2.2 RESTRAINTS
  - 4.2.2.1 High development and production cost of advanced biomaterials
- 4.2.3 OPPORTUNITIES
  - 4.2.3.1 Expanding applications in tissue engineering and regenerative medicine
  - 4.2.3.2 Development of novel biomaterials
- 4.2.4 CHALLENGES
  - 4.2.4.1 Concerns related to biocompatibility, safety, and adverse immune responses
4.3 UNMET NEEDS & WHITE SPACES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 BARGAINING POWER OF SUPPLIERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
- 5.2.1 GDP TRENDS AND FORECAST
- 5.2.2 TRENDS IN GLOBAL BIOMATERIALS MARKET
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
- 5.4.1 ROLE IN ECOSYSTEM
5.5 PRICING ANALYSIS
- 5.5.1 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025
- 5.5.2 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025
5.6 TRADE ANALYSIS
- 5.6.1 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021-2025
- 5.6.2 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021-2025
- 5.6.3 IMPORT VOLUME FOR HS 7221 (STAINLESS STEEL), 2021-2025
- 5.6.4 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), 2021-2025
- 5.6.5 IMPORT DATA FOR HS CODE 284329 (SILVER), 2021-2025
- 5.6.6 EXPORT DATA FOR HS CODE 284329 (SILVER), 2021-2025
- 5.6.7 IMPORT VOLUME FOR HS 284329 (SILVER), 2021-2025
- 5.6.8 EXPORT VOLUME FOR HS CODE 284329 (SILVER), 2021-2025
- 5.6.9 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021-2025
- 5.6.10 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021-2025
- 5.6.11 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021-2025
- 5.6.12 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021-2025
- 5.6.13 IMPORT DATA FOR HS CODE 3910 (SILICONE), 2021-2025
- 5.6.14 EXPORT DATA FOR HS CODE 3910 (SILICONE), 2021-2025
- 5.6.15 IMPORT VOLUME FOR HS 3910 (SILICONE), 2021-2025
- 5.6.16 EXPORT VOLUME FOR HS CODE 3910 (SILICONE), 2021-2025
5.7 KEY CONFERENCES & EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.9 INVESTMENT & FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
- 5.10.1 SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING
- 5.10.2 STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS
- 5.10.3 ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP
5.11 IMPACT OF 2025 US TARIFF ON BIOMATERIALS MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 KEY TARIFF RATES
- 5.11.3 PRICE IMPACT ANALYSIS
- 5.11.4 IMPACT ON COUNTRY/REGION
  - 5.11.4.1 North America
  - 5.11.4.2 Europe
  - 5.11.4.3 Asia Pacific
- 5.11.5 IMPACT ON END-USE INDUSTRIES
  - 5.11.5.1 Medical device manufacturers
  - 5.11.5.2 Pharmaceutical & biotechnology companies

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

6.1 TECHNOLOGY ANALYSIS
- 6.1.1 KEY TECHNOLOGIES
  - 6.1.1.1 Precision technologies
  - 6.1.1.2 Biomimetics
- 6.1.2 ADJACENT TECHNOLOGIES
  - 6.1.2.1 3D bioprinting
  - 6.1.2.2 Electrospinning
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
- 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015-2025
- 6.3.2 LIST OF PATENTS
6.4 FUTURE APPLICATIONS
6.5 IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET
- 6.5.1 TOP USE CASES AND MARKET POTENTIAL
- 6.5.2 CASE STUDIES OF AI IMPLEMENTATION
- 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 6.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

7.1 REGIONAL REGULATIONS & COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK
- 7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 KEY BUYING CRITERIA, BY END USER
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM KEY END-USE INDUSTRIES
8.5 MARKET PROFITABILITY

9 BIOMATERIALS MARKET, BY TYPE

9.1 INTRODUCTION
9.2 METALLIC BIOMATERIALS
- 9.2.1 STAINLESS STEEL
  - 9.2.1.1 Favorable mechanical properties, corrosion resistance, and cost-effectiveness to drive usage
- 9.2.2 TITANIUM & TITANIUM ALLOYS
  - 9.2.2.1 Rising number of joint replacement procedures to aid market growth
- 9.2.3 COBALT-CHROME ALLOYS
  - 9.2.3.1 Low cost and excellent corrosion resistance to augment market growth
- 9.2.4 SILVER
  - 9.2.4.1 Toxic properties and low aesthetic to limit use of silver in biomaterial-based products
- 9.2.5 GOLD
  - 9.2.5.1 Expanding applications of gold nanoparticles to drive demand for gold biomaterials
- 9.2.6 MAGNESIUM
  - 9.2.6.1 Biodegradable characteristics of magnesium to aid segment growth
- 9.2.7 OTHER METALLIC BIOMATERIALS
9.3 POLYMERIC BIOMATERIALS
- 9.3.1 POLYMETHYLMETHACRYLATE (PMMA)
  - 9.3.1.1 Long-standing clinical record demonstrating safety and biocompatibility to spur market growth
- 9.3.2 POLYETHYLENE
  - 9.3.2.1 Wear and tear resistance of polyethylene to popularize usage in hip and knee joint replacements
- 9.3.3 POLYESTER
  - 9.3.3.1 Biodegradable nature and biocompatibility to boost use in various medical applications
- 9.3.4 POLYVINYLCHLORIDE
  - 9.3.4.1 Heavy chlorine content of polyvinylchloride to hamper market growth
- 9.3.5 SILICONE RUBBER
  - 9.3.5.1 Non-reactive, stable, and resistant in extreme environments and temperatures to drive adoption of silicone rubber
- 9.3.6 NYLON
  - 9.3.6.1 Low weight, corrosion resistance, and wide applications to propel market demand
- 9.3.7 POLYETHERETHERKETONE
  - 9.3.7.1 Polyetheretherketone to gain popularity as viable alternative to metals
- 9.3.8 OTHER POLYMERIC BIOMATERIALS
9.4 CERAMIC BIOMATERIALS
- 9.4.1 CALCIUM PHOSPHATE
  - 9.4.1.1 Close structural and chemical resemblance to natural bone and teeth to drive adoption in biomedical applications
- 9.4.2 ZIRCONIA
  - 9.4.2.1 Bio-inertness and low wear rate of zirconia to boost market adoption
- 9.4.3 ALUMINUM OXIDE
  - 9.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive market
- 9.4.4 CALCIUM SULFATE
  - 9.4.4.1 Better biocompatibility and bioresorbability to augment market adoption
- 9.4.5 CARBON
  - 9.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment to drive market growth
- 9.4.6 GLASS
  - 9.4.6.1 Rising number of orthopedic and dental procedures to fuel demand for glass biomaterials
9.5 NATURAL BIOMATERIALS
- 9.5.1 HYALURONIC ACID
  - 9.5.1.1 Rising incidences of osteoarthritis to drive hyaluronic acid biomaterials market
- 9.5.2 COLLAGEN
  - 9.5.2.1 High tensile strength to be useful in plastic and cosmetic surgeries, cardiology, ophthalmology, and drug delivery
- 9.5.3 FIBRIN
  - 9.5.3.1 Fibrin biomaterials to be useful in clinical practice for controlling bleeding and accelerating wound repair
- 9.5.4 CELLULOSE
  - 9.5.4.1 Cellulose to be useful in wound healing, skin regeneration, and ophthalmology
- 9.5.5 CHITIN
  - 9.5.5.1 Chitin to accelerate skin regeneration and possess high biocompatibility
- 9.5.6 ALGINATES
  - 9.5.6.1 Use in wound healing, tissue engineering & regenerative medicine, and drug delivery to drive adoption
- 9.5.7 GELATIN
  - 9.5.7.1 Low cost and comparable biocompatibility of gelatin to fuel market adoption
- 9.5.8 CHITOSAN
  - 9.5.8.1 Non-toxicity of Chitosan to increase adoption in biomedical research
- 9.5.9 SILK
  - 9.5.9.1 Flexibility and adhesive abilities to drive usage in wound healing applications
- 9.5.10 OTHER NATURAL BIOMATERIALS

10 BIOMATERIALS MARKET, BY APPLICATION

10.1 INTRODUCTION
10.2 ORTHOPEDIC
- 10.2.1 JOINT REPLACEMENT
  - 10.2.1.1 Knee replacement
    - 10.2.1.1.1 Rising count of knee replacement procedures globally to drive market growth
  - 10.2.1.2 Hip replacement
    - 10.2.1.2.1 Hip & knee joint replacements to be most commonly performed procedures
  - 10.2.1.3 Shoulder replacement
    - 10.2.1.3.1 Increasing shoulder surgeries to drive production of implants
  - 10.2.1.4 Other joint replacement applications
- 10.2.2 BIORESORBABLE TISSUE FIXATION
  - 10.2.2.1 Suture anchors
    - 10.2.2.1.1 Growing awareness about suture anchor devices to propel market growth
  - 10.2.2.2 Interference screws
    - 10.2.2.2.1 Growing ACL reconstruction procedures to contribute to market growth
  - 10.2.2.3 Meniscal repair tacks
    - 10.2.2.3.1 Rising sports injuries to fuel growth in meniscal repair tacks market
  - 10.2.2.4 Meshes
    - 10.2.2.4.1 Wear resistance and proper shaping of bioresorbable implants to increase demand for bioresorbable meshes
- 10.2.3 SPINE SURGERIES
  - 10.2.3.1 Spinal fusion
    - 10.2.3.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth
  - 10.2.3.2 Minimally invasive fusion
    - 10.2.3.2.1 Lesser post-surgery pain and faster recovery to drive demand for minimally invasive fusion procedures
  - 10.2.3.3 Motion preservation & dynamic stabilization
    - 10.2.3.3.1 Pedicle-based rod systems
      - 10.2.3.3.1.1 Rising geriatric population to result in market growth
    - 10.2.3.3.2 Interspinous spacers
      - 10.2.3.3.2.1 High prevalence of degenerative spinal conditions to contribute to market growth
    - 10.2.3.3.3 Artificial discs
      - 10.2.3.3.3.1 High biocompatibility to increase usage in artificial discs
- 10.2.4 FRACTURE FIXATION DEVICES
  - 10.2.4.1 Bone plates
    - 10.2.4.1.1 High biocompatibility of biomaterials to be an integral component of bone plates
  - 10.2.4.2 Screws
    - 10.2.4.2.1 Metallic biomaterial screws to be extensively used in orthopedic procedures
  - 10.2.4.3 Pins
    - 10.2.4.3.1 Nonreactive nature of metallic biomaterial pins to favor usage in fracture fixation
  - 10.2.4.4 Rods
    - 10.2.4.4.1 High rigidity, easy mobility, and cost efficiency to make rods preferred for fracture fixation procedures
  - 10.2.4.5 Wires
    - 10.2.4.5.1 Wires made up of metallic biomaterials to help treat fractures of small bones
- 10.2.5 ORTHOBIOLOGICS
  - 10.2.5.1 Rising cases of osteoarthritis to drive growth in viscosupplementation market
10.3 CARDIOVASCULAR
- 10.3.1 CATHETERS
  - 10.3.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive market
- 10.3.2 STENTS
  - 10.3.2.1 Increasing number of coronary intervention procedures to boost demand for implantable stents
- 10.3.3 IMPLANTABLE CARDIAC DEFIBRILLATORS
  - 10.3.3.1 Growing geriatric population and rising prevalence of chronic diseases to drive market
- 10.3.4 PACEMAKERS
  - 10.3.4.1 High prevalence of bradycardia to aid demand for pacemakers
- 10.3.5 SENSORS
  - 10.3.5.1 Increasing prevalence of cardiac disorders to boost demand for cardiovascular sensors
- 10.3.6 HEART VALVES
  - 10.3.6.1 Growing geriatric population to increase demand for prosthetic valves
- 10.3.7 VASCULAR GRAFTS
  - 10.3.7.1 Focus on research on use of biomaterials in vascular grafts to open opportunities for market growth
- 10.3.8 GUIDEWIRES
  - 10.3.8.1 Guidewires to be used for guiding catheters and placing stents inside the heart
- 10.3.9 OTHER CARDIOVASCULAR APPLICATIONS
10.4 OPHTHALMOLOGY
- 10.4.1 CONTACT LENSES
  - 10.4.1.1 Growing cases of refractive errors and preference for contact lenses over spectacles to drive market growth
- 10.4.2 INTRAOCULAR LENSES
  - 10.4.2.1 Increasing prevalence of cataracts to boost number of cataract surgeries performed
- 10.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
  - 10.4.3.1 Increasing funding and research activities for developing bionic eyes to propel segment growth
- 10.4.4 SYNTHETIC CORNEAS
  - 10.4.4.1 Increasing number of corneal blindness cases globally to boost demand for synthetic collagen biomaterials
- 10.4.5 OTHER OPHTHALMOLOGY APPLICATIONS
10.5 DENTAL
- 10.5.1 DENTAL IMPLANTS
  - 10.5.1.1 Rising awareness about dental health and increasing dental procedures to augment market growth
- 10.5.2 DENTAL BONE GRAFTS & SUBSTITUTES
  - 10.5.2.1 Growing demand for dental implants during cosmetic dentistry to drive market
- 10.5.3 DENTAL MEMBRANES
  - 10.5.3.1 Dental membranes in oral and periodontal surgery to prevent unwanted infections in oral cavity
- 10.5.4 TISSUE REGENERATION MATERIALS
  - 10.5.4.1 Increasing prevalence of periodontal disease to augment market growth
10.6 PLASTIC SURGERY
- 10.6.1 SOFT TISSUE FILLERS
  - 10.6.1.1 Long-lasting capacity and fewer allergic reactions to drive demand for soft-tissue fillers
- 10.6.2 CRANIOFACIAL SURGERY
  - 10.6.2.1 Increasing incidence of trauma cases and head & neck cancer to augment market growth
- 10.6.3 FACIAL WRINKLE TREATMENT
  - 10.6.3.1 Increase in demand for non-surgical cosmetic treatments to propel market growth
- 10.6.4 BIOENGINEERED SKINS
  - 10.6.4.1 Increasing incidence of trauma cases and head & neck cancer to increase number of craniofacial surgeries
- 10.6.5 PERIPHERAL NERVE REPAIR
  - 10.6.5.1 Increasing incidence of trauma cases to rise in peripheral nerve injuries
- 10.6.6 ACELLULAR DERMAL MATRICES
  - 10.6.6.1 Ability to provide scaffold for tissue regeneration and reduce risk of immune rejection and adverse reactions to drive segment
10.7 WOUND HEALING
- 10.7.1 WOUND CLOSURE DEVICES
  - 10.7.1.1 Sutures
    - 10.7.1.1.1 Sutures to be used as advanced biologically active components for better drug delivery
  - 10.7.1.2 Staples
    - 10.7.1.2.1 Ease of placement and ability to shorten closure to augment segment growth
- 10.7.2 SURGICAL HEMOSTATS
  - 10.7.2.1 Surgical hemostats to control bleeding and reduce frequent blood transfusions during surgical procedures
- 10.7.3 INTERNAL TISSUE SEALANTS
  - 10.7.3.1 Increasing number of surgeries to drive use of internal tissue sealants
- 10.7.4 ADHESION BARRIERS
  - 10.7.4.1 Focus on inflammatory healing process to drive adoption of adhesion barriers in surgical procedures
- 10.7.5 HERNIA MESHES
  - 10.7.5.1 Polymeric biomaterial-based meshes to be used in hernia repair
- 10.7.6 SKIN SUBSTITUTES
  - 10.7.6.1 Focus on prompting tissue regeneration and replacing damaged skin with functional tissue to aid market growth
10.8 TISSUE ENGINEERING
- 10.8.1 SCAFFOLDS FOR BIOMATERIALS
  - 10.8.1.1 Rise in organ transplantation procedures to drive market
- 10.8.2 NANOMATERIALS FOR BIOSENSING
  - 10.8.2.1 Rising research in nanotechnology to augment market growth
- 10.8.3 TAILORING OF INORGANIC NANOPARTICLES
  - 10.8.3.1 Growing demand for nanotechnological medical products to drive market
10.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
- 10.9.1 SHUNTING SYSTEMS
  - 10.9.1.1 Rising cases of hydrocephalus to boost market growth
- 10.9.2 CORTICAL NEURAL PROSTHETICS
  - 10.9.2.1 Increased use of polymer-coated CNPs to treat paralyzed patients
- 10.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR
  - 10.9.3.1 Increasing incidence of spinal cord surgeries to drive demand for hydrogel scaffolds
- 10.9.4 NEURAL STEM CELL ENCAPSULATION
  - 10.9.4.1 Lack of substitutes for neurotrauma treatment to boost market growth
10.10 URINARY
- 10.10.1 URINARY CATHETERS
  - 10.10.1.1 Rise in implant-related cases of biofilm-associated infections to hinder market growth
- 10.10.2 URETHRAL STENTS
- 10.10.3 OTHER URINARY APPLICATIONS
10.11 OTHER APPLICATIONS
- 10.11.1 DRUG DELIVERY SYSTEMS
- 10.11.2 GASTROINTESTINAL APPLICATIONS
- 10.11.3 BARIATRIC SURGERY

11 BIOMATERIALS MARKET, BY END USER

11.1 INTRODUCTION
11.2 MEDICAL DEVICE MANUFACTURERS
- 11.2.1 DEMOGRAPHIC SHIFTS, TECHNOLOGICAL INNOVATION, AND EXPANDING CLINICAL APPLICATIONS TO DRIVE MARKET
11.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 11.3.1 INVESTMENT AND INNOVATION MOMENTUM IN PHARMA & BIOTECH TO ACCELERATE GLOBAL BIOMATERIAL ADOPTION
11.4 OTHER END USERS

12 BIOMATERIALS MARKET, BY REGION

12.1 INTRODUCTION
12.2 NORTH AMERICA
- 12.2.1 US
  - 12.2.1.1 Rising incidence of cancer and ongoing research in developing biocompatible materials to drive market
- 12.2.2 CANADA
  - 12.2.2.1 Growing incidence of cardiovascular diseases to propel market growth
12.3 EUROPE
- 12.3.1 GERMANY
  - 12.3.1.1 Rising focus on clinical research and increasing number of patent approvals to aid market growth
- 12.3.2 UK
  - 12.3.2.1 Increasing research activities and rising number of cardiovascular procedures to support market growth
- 12.3.3 FRANCE
  - 12.3.3.1 Increased healthcare expenditure and structured regulatory framework to augment market growth
- 12.3.4 ITALY
  - 12.3.4.1 Rising prevalence of neurological and cardiovascular disorders to boost market growth
- 12.3.5 SPAIN
  - 12.3.5.1 Increased focus on research for biomaterial development to propel market growth
- 12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
- 12.4.1 CHINA
  - 12.4.1.1 Lucrative medical devices industry and large geriatric population to drive market
- 12.4.2 JAPAN
  - 12.4.2.1 Growing medical devices industry and rising focus on medical research to support market growth
- 12.4.3 INDIA
  - 12.4.3.1 Large population base and high focus on medical tourism to aid market growth
- 12.4.4 SOUTH KOREA
  - 12.4.4.1 High demand for healthcare services and advanced treatments to spur market growth
- 12.4.5 AUSTRALIA
  - 12.4.5.1 Strategic public and sector-wide investments with clinical trial system reform to underpin biomedical research growth
- 12.4.6 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
- 12.5.1 BRAZIL
  - 12.5.1.1 Gradual increase in pharmaceutical R&D to fuel market growth
- 12.5.2 MEXICO
  - 12.5.2.1 Rising number of cosmetic procedures to boost adoption of biomaterials
- 12.5.3 ARGENTINA
  - 12.5.3.1 Increased incidence of cardiovascular diseases and favorable government healthcare system to aid market growth
- 12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST
- 12.6.1 GCC COUNTRIES
  - 12.6.1.1 Kingdom of Saudi Arabia
    - 12.6.1.1.1 Increasing prevalence of cardiovascular diseases to drive market
  - 12.6.1.2 UAE
    - 12.6.1.2.1 Strategic partnerships and regulatory alignment to drive global biomaterials market growth
  - 12.6.1.3 Rest of GCC countries
- 12.6.2 REST OF MIDDLE EAST
12.7 AFRICA
- 12.7.1 EXPANSION IN HEALTHCARE INDUSTRY AND SUPPORTIVE REGULATORY POLICIES TO AID MARKET GROWTH

13 COMPETITIVE LANDSCAPE

13.1 INTRODUCTION
13.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS
- 13.2.1 STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET
13.3 REVENUE ANALYSIS, 2023-2025
13.4 MARKET SHARE ANALYSIS, 2025
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
- 13.5.1 STARS
- 13.5.2 EMERGING LEADERS
- 13.5.3 PERVASIVE PLAYERS
- 13.5.4 PARTICIPANTS
- 13.5.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2025
  - 13.5.5.1 Company footprint
  - 13.5.5.2 Region footprint
  - 13.5.5.3 Type footprint
  - 13.5.5.4 Application footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
- 13.6.1 PROGRESSIVE COMPANIES
- 13.6.2 RESPONSIVE COMPANIES
- 13.6.3 DYNAMIC COMPANIES
- 13.6.4 STARTING BLOCKS
- 13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  - 13.6.5.1 List of key startups/SMEs
  - 13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION & FINANCIAL METRICS
- 13.7.1 FINANCIAL METRICS
- 13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES
- 13.9.2 DEALS
- 13.9.3 EXPANSIONS

14 COMPANY PROFILES

14.1 KEY PLAYERS
- 14.1.1 BASF SE
  - 14.1.1.1 Business overview
  - 14.1.1.2 Products/Services/Solutions offered
  - 14.1.1.3 Recent developments
    - 14.1.1.3.1 Deals
    - 14.1.1.3.2 Other developments
  - 14.1.1.4 MnM view
    - 14.1.1.4.1 Right to win
    - 14.1.1.4.2 Strategic choices
    - 14.1.1.4.3 Weaknesses & competitive threats
- 14.1.2 COVESTRO AG
  - 14.1.2.1 Business overview
  - 14.1.2.2 Products/Services/Solutions offered
  - 14.1.2.3 Recent developments
    - 14.1.2.3.1 Product launches
    - 14.1.2.3.2 Deals
    - 14.1.2.3.3 Expansions
    - 14.1.2.3.4 Other developments
  - 14.1.2.4 MnM view
    - 14.1.2.4.1 Right to win
    - 14.1.2.4.2 Strategic choices
    - 14.1.2.4.3 Weaknesses & competitive threats
- 14.1.3 CELANESE CORPORATION
  - 14.1.3.1 Business overview
  - 14.1.3.2 Products/Services/Solutions offered
  - 14.1.3.3 Recent developments
    - 14.1.3.3.1 Deals
  - 14.1.3.4 MnM view
    - 14.1.3.4.1 Right to win
    - 14.1.3.4.2 Strategic choices
    - 14.1.3.4.3 Weaknesses & competitive threats
- 14.1.4 CARPENTER TECHNOLOGY CORPORATION
  - 14.1.4.1 Business overview
  - 14.1.4.2 Products/Services/Solutions offered
    - 14.1.4.2.1 Other developments
  - 14.1.4.3 MnM view
    - 14.1.4.3.1 Right to win
    - 14.1.4.3.2 Strategic choices
    - 14.1.4.3.3 Weaknesses & competitive threats
- 14.1.5 EVONIK INDUSTRIES AG
  - 14.1.5.1 Business overview
  - 14.1.5.2 Products/Services/Solutions offered
  - 14.1.5.3 Recent developments
    - 14.1.5.3.1 Product launches
    - 14.1.5.3.2 Deals
  - 14.1.5.4 MnM view
    - 14.1.5.4.1 Right to win
    - 14.1.5.4.2 Strategic choices
    - 14.1.5.4.3 Weaknesses & competitive threats
- 14.1.6 DSM
  - 14.1.6.1 Business overview
  - 14.1.6.2 Products/Services/Solutions offered
  - 14.1.6.3 Recent developments
    - 14.1.6.3.1 Deals
    - 14.1.6.3.2 Expansions
- 14.1.7 CORBION NV
  - 14.1.7.1 Business overview
  - 14.1.7.2 Products/Services/Solutions offered
  - 14.1.7.3 Recent developments
    - 14.1.7.3.1 Expansions
- 14.1.8 VICTREX PLC
  - 14.1.8.1 Business overview
  - 14.1.8.2 Products/Services/Solutions offered
  - 14.1.8.3 Recent developments
    - 14.1.8.3.1 Product launches
    - 14.1.8.3.2 Expansions
- 14.1.9 MITSUBISHI CHEMICAL CORPORATION
  - 14.1.9.1 Business overview
  - 14.1.9.2 Products/Services/Solutions offered
- 14.1.10 COORSTEK INC.
  - 14.1.10.1 Business overview
  - 14.1.10.2 Products/Services/Solutions offered
- 14.1.11 BERKELEY ADVANCED BIOMATERIALS
  - 14.1.11.1 Business overview
  - 14.1.11.2 Products/Services/Solutions offered
- 14.1.12 CAM BIOCERAMICS B.V.
  - 14.1.12.1 Business overview
  - 14.1.12.2 Products/Services/Solutions offered
  - 14.1.12.3 Recent developments
    - 14.1.12.3.1 Deals
- 14.1.13 ZEUS COMPANY INC.
  - 14.1.13.1 Business overview
  - 14.1.13.2 Products/Services/Solutions offered
  - 14.1.13.3 Recent developments
    - 14.1.13.3.1 Product launches
    - 14.1.13.3.2 Expansions
- 14.1.14 AMETEK INC.
  - 14.1.14.1 Business overview
  - 14.1.14.2 Products/Services/Solutions offered
  - 14.1.14.3 Recent developments
    - 14.1.14.3.1 Deals
    - 14.1.14.3.2 Expansions
- 14.1.15 GELITA AG
  - 14.1.15.1 Business overview
  - 14.1.15.2 Products/Services/Solutions offered
  - 14.1.15.3 Recent developments
    - 14.1.15.3.1 Product launches
14.2 OTHER PLAYERS
- 14.2.1 COLLAGEN SOLUTIONS (US) LLC
- 14.2.2 BIOCOMPOSITES
- 14.2.3 NOBLE BIOMATERIALS, INC.
- 14.2.4 REGENITY
- 14.2.5 KURARAY CO., LTD.
- 14.2.6 SOLESIS
- 14.2.7 INSTITUT STRAUMANN AG
- 14.2.8 FOSTER CORPORATION
- 14.2.9 CDI PRODUCTS
- 14.2.10 REVBIO, INC.

15 RESEARCH METHODOLOGY

15.1 RESEARCH DATA
- 15.1.1 SECONDARY DATA
  - 15.1.1.1 Key objectives of secondary research
- 15.1.2 PRIMARY DATA
  - 15.1.2.1 Breakdown of primaries
  - 15.1.2.2 Key objectives of primary research
15.2 MARKET ESTIMATION METHODOLOGY
15.3 MARKET SIZE ESTIMATION
- 15.3.1 COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
- 15.3.2 MNM REPOSITORY ANALYSIS
- 15.3.3 PRIMARY INTERVIEWS
- 15.3.4 INSIGHTS OF PRIMARY EXPERTS
- 15.3.5 TOP-DOWN APPROACH
15.4 MARKET GROWTH RATE PROJECTIONS
15.5 DATA TRIANGULATION
15.6 STUDY ASSUMPTIONS
15.7 RESEARCH LIMITATIONS
15.8 RISK ANALYSIS

16 APPENDIX

16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS

Product Code: BT 1556

List of Tables

TABLE 1 BIOMATERIALS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF FACTORS IN BIOMATERIALS MARKET
TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON BIOMATERIALS MARKET
TABLE 4 ROLE OF KEY COMPANIES (DEMAND/SUPPLY SIDES) IN BIOMATERIALS MARKET ECOSYSTEM
TABLE 5 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD)
TABLE 6 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025 (USD)
TABLE 7 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 8 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 9 IMPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021-2025 (TONS)
TABLE 10 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021-2025 (TONS)
TABLE 11 IMPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 12 EXPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 13 IMPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021-2025 (TONS)
TABLE 14 EXPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021-2025 (TONS)
TABLE 15 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 16 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 17 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021-2025 (TONS)
TABLE 18 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021-2025 (TONS)
TABLE 19 IMPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 20 EXPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 21 IMPORT VOLUME FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021-2025 (TONS)
TABLE 22 EXPORT VOLUME FOR HS CODE 3910, BY COUNTRY, 2021-2025 (TONS)
TABLE 23 KEY CONFERENCES & EVENTS IN BIOMATERIALS MARKET, JANUARY 2026-DECEMBER 2027
TABLE 24 CASE STUDY 1: SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING
TABLE 25 CASE STUDY 2: STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS
TABLE 26 CASE STUDY 3: ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP
TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 28 INDICATIVE LIST OF PATENTS IN BIOMATERIALS MARKET, 2025
TABLE 29 CASE STUDIES OF AI IMPLEMENTATION IN BIOMATERIALS MARKET
TABLE 30 CLIENT'S READINESS TO ADOPT GENERATIVE AI IN BIOMATERIALS MARKET
TABLE 31 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 32 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 33 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 34 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 35 COUNTRY-WISE REGULATORY SCENARIO FOR BIOMATERIAL MANUFACTURERS
TABLE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
TABLE 37 KEY BUYING CRITERIA, BY END USER
TABLE 38 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION
TABLE 39 BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 40 METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 41 METALLIC BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 42 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 43 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 44 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 45 SILVER BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 46 GOLD BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 47 MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 48 OTHER METALLIC BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 49 APPLICATIONS OF SYNTHETIC POLYMERS
TABLE 50 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 51 POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 52 POLYMETHYLMETHACRYLATE (PMMA) BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 53 POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 54 POLYESTER BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 55 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 56 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 57 NYLON BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 58 POLYETHERETHERKETONE (PEEK) BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 59 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 60 CERAMIC BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 61 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 62 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 63 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 64 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 65 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 66 CARBON BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 67 GLASS BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 68 APPLICATIONS OF NATURAL BIOMATERIALS
TABLE 69 NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 70 NATURAL BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 71 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 72 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 73 FIBRIN BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 74 CELLULOSE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 75 CHITIN BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 76 ALGINATES BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 77 GELATIN BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 78 CHITOSAN BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 79 SILK BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 80 OTHER NATURAL BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 81 BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 82 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 83 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 85 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 86 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 87 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 88 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 89 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 90 BIORESORBABLE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 91 BIORESORBABLE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 92 SUTURE ANCHOR BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 93 INTERFERENCE SCREW BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 94 MENISCAL REPAIR TACK BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 95 MESH BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 96 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 97 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 98 SPINAL FUSION BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 99 MINIMALLY INVASIVE FUSION BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 100 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 101 MOTION PRESERVATION & DYNAMIC STABILIZATION BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 102 PEDICLE-BASED ROD SYSTEM BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 103 INTERSPINOUS SPACER BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 104 ARTIFICIAL DISC BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 105 BIOMATERIALS MARKET FOR FRACTURE FIXATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 106 FRACTURE FIXATION BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 107 BONE PLATE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 108 SCREW BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 109 PIN BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 110 ROD BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 111 WIRE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 112 ORTHOBIOLOGICS BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 113 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 114 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 115 CATHETER BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 116 STENT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 117 IMPLANTABLE CARDIAC DEFIBRILLATOR BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 118 PACEMAKER BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 119 SENSOR BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 120 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
TABLE 121 HEART VALVE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 122 VASCULAR GRAFT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 123 GUIDEWIRE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 124 OTHER CARDIOVASCULAR BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 125 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 126 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 127 CONTACT LENSE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 128 INTRAOCULAR LENSE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 129 FUNCTIONAL REPLACEMENTS OF OCULAR TISSUE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 130 SYNTHETIC CORNEA BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 131 OTHER OPHTHALMOLOGY BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 132 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 133 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 134 DENTAL IMPLANT BIOMAERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 135 DENTAL BONE GRAFT & SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 136 DENTAL MEMBRANE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 137 TISSUE REGENERATION BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 138 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 139 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 140 SOFT TISSUE FILLERS BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 141 CRANIOFACIAL SURGERY BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 142 FACIAL WRINKLE TREATMENT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 143 BIOENGINEERED SKIN BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 144 PERIPHERAL NERVE REPAIR BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 145 ACELLULAR DERMAL MATRICE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 146 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 147 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 148 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 149 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 150 SUTURE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 151 STAPLE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 152 SURGICAL HEMOSTAT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 153 INTERNAL TISSUE SEALANT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 154 ADHESION BARRIER BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 155 HERNIA MESH BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 156 SKIN SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 157 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 158 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 159 SCAFFOLDS FOR BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 160 NANOMATERIALS FOR BIOSENSING BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 161 TAILORING OF INORGANIC NANOPARTICLE BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 162 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 163 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 164 SHUNTING SYSTEM BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 165 CORTICAL NEURAL PROSTHETIC BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 166 HYDROGEL SCAFFOLD FOR CNS REPAIR BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 167 NEURAL STEM CELL ENCAPSULATION BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 168 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 169 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 170 URINARY CATHETER BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 171 URETHRAL STENT BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 172 OTHER URINARY BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 173 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 174 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 175 DRUG DELIVERY SYSTEM BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 176 GASTROINTESTINAL APPLICATION BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 177 BARIATRIC SURGERY BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 178 BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 179 BIOMATERIALS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2024-2031(USD MILLION)
TABLE 180 BIOMATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 181 BIOMATERIALS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 182 BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 183 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 184 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 185 NORTH AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 186 NORTH AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 187 NORTH AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 188 NORTH AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 189 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 190 NORTH AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 191 NORTH AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 192 NORTH AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 193 NORTH AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 194 NORTH AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 NORTH AMERICA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 NORTH AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 197 NORTH AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 198 NORTH AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 199 NORTH AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 200 NORTH AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 201 NORTH AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 202 NORTH AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 203 NORTH AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 204 NORTH AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 205 NORTH AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 206 NORTH AMERICA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 207 US: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 208 US: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 209 US: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 210 US: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 211 US: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 212 US: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 213 US: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 214 US: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 215 US: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 216 US: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 217 US: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 218 US: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 219 US: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 220 US: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 221 US: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 222 US: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 223 US: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 224 US: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 225 US: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 226 US: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 227 US: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 228 US: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 229 US: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 230 CANADA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 CANADA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 232 CANADA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 233 CANADA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 234 CANADA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 235 CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 236 CANADA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 237 CANADA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 238 CANADA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 239 CANADA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 240 CANADA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 241 CANADA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 242 CANADA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 243 CANADA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 244 CANADA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 245 CANADA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 246 CANADA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 247 CANADA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 248 CANADA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 249 CANADA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 250 CANADA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 251 CANADA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 252 CANADA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 253 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 254 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 255 EUROPE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 256 EUROPE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 257 EUROPE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 258 EUROPE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 259 EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 260 EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 261 EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 262 EUROPE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 263 EUROPE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 264 EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 265 EUROPE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 266 EUROPE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 267 EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 268 EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 269 EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 270 EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 271 EUROPE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 272 EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 273 EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 274 EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 275 EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 276 EUROPE: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 277 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 278 GERMANY: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 279 GERMANY: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 280 GERMANY: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 281 GERMANY: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 282 GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 283 GERMANY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 284 GERMANY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 285 GERMANY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 286 GERMANY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 287 GERMANY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 288 GERMANY: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 289 GERMANY: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 290 GERMANY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 291 GERMANY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 292 GERMANY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 293 GERMANY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 294 GERMANY: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 295 GERMANY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 296 GERMANY: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 297 GERMANY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 298 GERMANY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 299 GERMANY: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 300 UK: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 301 UK: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 302 UK: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 303 UK: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 304 UK: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 305 UK: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 306 UK: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 307 UK: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 308 UK: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 309 UK: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 310 UK: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 311 UK: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 312 UK: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 313 UK: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 314 UK: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 315 UK: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 316 UK: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 317 UK: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 318 UK: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 319 UK: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 320 UK: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 321 UK: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 322 UK: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 323 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 324 FRANCE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 325 FRANCE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 326 FRANCE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 327 FRANCE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 328 FRANCE: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 329 FRANCE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 330 FRANCE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 331 FRANCE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 332 FRANCE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 333 FRANCE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 334 FRANCE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 335 FRANCE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 336 FRANCE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 337 FRANCE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 338 FRANCE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 339 FRANCE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 340 FRANCE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 341 FRANCE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 342 FRANCE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 343 FRANCE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 344 FRANCE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 345 FRANCE: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 346 ITALY: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 347 ITALY: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 348 ITALY: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 349 ITALY: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 350 ITALY: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 351 ITALY: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 352 ITALY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 353 ITALY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 354 ITALY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 355 ITALY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 356 ITALY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 357 ITALY: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 358 ITALY: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 359 ITALY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 360 ITALY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 361 ITALY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 362 ITALY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 363 ITALY: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 364 ITALY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 365 ITALY: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 366 ITALY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 367 ITALY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 368 ITALY: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 369 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 370 SPAIN: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 371 SPAIN: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 372 SPAIN: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 373 SPAIN: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 374 SPAIN: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 375 SPAIN: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 376 SPAIN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 377 SPAIN: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 378 SPAIN: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 379 SPAIN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 380 SPAIN: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 381 SPAIN: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 382 SPAIN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 383 SPAIN: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 384 SPAIN: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 385 SPAIN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 386 SPAIN: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 387 SPAIN: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 388 SPAIN: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 389 SPAIN: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 390 SPAIN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 391 SPAIN: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 392 REST OF EUROPE: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 393 REST OF EUROPE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 394 REST OF EUROPE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 395 REST OF EUROPE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 396 REST OF EUROPE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 397 REST OF EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 398 REST OF EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 399 REST OF EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 400 REST OF EUROPE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 401 REST OF EUROPE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 402 REST OF EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 403 REST OF EUROPE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 404 REST OF EUROPE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 405 REST OF EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 406 REST OF EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 407 REST OF EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 408 REST OF EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 409 REST OF EUROPE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 410 REST OF EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 411 REST OF EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 412 REST OF EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 413 REST OF EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 414 REST OF EUROPE: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 415 ASIA PACIFIC: BIOMATERIALS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 416 ASIA PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 417 ASIA PACIFIC: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 418 ASIA PACIFIC: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 419 ASIA PACIFIC: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 420 ASIA PACIFIC: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 421 ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 422 ASIA PACIFIC: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 423 ASIA PACIFIC: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 424 ASIA PACIFIC: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 425 ASIA PACIFIC: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 426 ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 427 ASIA PACIFIC: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 428 ASIA PACIFIC: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 429 ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 430 ASIA PACIFIC: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 431 ASIA PACIFIC: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 432 ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 433 ASIA PACIFIC: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 434 ASIA PACIFIC: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 435 ASIA PACIFIC: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 436 ASIA PACIFIC: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 437 ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 438 ASIA PACIFIC: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 439 CHINA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 440 CHINA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 441 CHINA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 442 CHINA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 443 CHINA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 444 CHINA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 445 CHINA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 446 CHINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 447 CHINA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 448 CHINA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 449 CHINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 450 CHINA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 451 CHINA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 452 CHINA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 453 CHINA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 454 CHINA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 455 CHINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 456 CHINA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 457 CHINA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 458 CHINA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 459 CHINA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 460 CHINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 461 CHINA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 462 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 463 JAPAN: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 464 JAPAN: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 465 JAPAN: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 466 JAPAN: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 467 JAPAN: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 468 JAPAN: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 469 JAPAN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 470 JAPAN: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 471 JAPAN: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 472 JAPAN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 473 JAPAN: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 474 JAPAN: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 475 JAPAN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 476 JAPAN: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 477 JAPAN: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 478 JAPAN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 479 JAPAN: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 480 JAPAN: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 481 JAPAN: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 482 JAPAN: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 483 JAPAN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 484 JAPAN: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 485 INDIA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 486 INDIA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 487 INDIA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 488 INDIA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 489 INDIA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 490 INDIA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 491 INDIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 492 INDIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 493 INDIA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 494 INDIA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 495 INDIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 496 INDIA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 497 INDIA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 498 INDIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 499 INDIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 500 INDIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 501 INDIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 502 INDIA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 503 INDIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 504 INDIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 505 INDIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 506 INDIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 507 INDIA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 508 SOUTH KOREA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 509 SOUTH KOREA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 510 SOUTH KOREA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 511 SOUTH KOREA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 512 SOUTH KOREA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 513 SOUTH KOREA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 514 SOUTH KOREA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 515 SOUTH KOREA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 516 SOUTH KOREA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 517 SOUTH KOREA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 518 SOUTH KOREA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 519 SOUTH KOREA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 520 SOUTH KOREA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 521 SOUTH KOREA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 522 SOUTH KOREA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 523 SOUTH KOREA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 524 SOUTH KOREA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 525 SOUTH KOREA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 526 SOUTH KOREA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 527 SOUTH KOREA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 528 SOUTH KOREA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 529 SOUTH KOREA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 530 SOUTH KOREA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 531 AUSTRALIA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 532 AUSTRALIA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 533 AUSTRALIA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 534 AUSTRALIA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 535 AUSTRALIA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 536 AUSTRALIA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 537 AUSTRALIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 538 AUSTRALIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 539 AUSTRALIA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 540 AUSTRALIA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 541 AUSTRALIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 542 AUSTRALIA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 543 AUSTRALIA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 544 AUSTRALIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 545 AUSTRALIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 546 AUSTRALIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 547 AUSTRALIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 548 AUSTRALIA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 549 AUSTRALIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 550 AUSTRALIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 551 AUSTRALIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 552 AUSTRALIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 553 AUSTRALIA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 554 REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 555 REST OF ASIA PACIFIC: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 556 REST OF ASIA PACIFIC: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 557 REST OF ASIA PACIFIC: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 558 REST OF ASIA PACIFIC: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 559 REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 560 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 561 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 562 REST OF ASIA PACIFIC: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 563 REST OF ASIA PACIFIC: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 564 REST OF ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 565 REST OF ASIA PACIFIC : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 566 REST OF ASIA PACIFIC: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 567 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 568 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 569 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 570 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 571 REST OF ASIA PACIFIC: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 572 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 573 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 574 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 575 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 576 REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 577 LATIN AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 578 LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 579 LATIN AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 580 LATIN AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 581 LATIN AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 582 LATIN AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 583 LATIN AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 584 LATIN AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 585 LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 586 LATIN AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 587 LATIN AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 588 LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 589 LATIN AMERICA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 590 LATIN AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 591 LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 592 LATIN AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 593 LATIN AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 594 LATIN AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 595 LATIN AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 596 LATIN AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 597 LATIN AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 598 LATIN AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 599 LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 600 LATIN AMERICA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 601 BRAZIL: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 602 BRAZIL: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 603 BRAZIL: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 604 BRAZIL: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 605 BRAZIL: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 606 BRAZIL: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 607 BRAZIL: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 608 BRAZIL: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 609 BRAZIL: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 610 BRAZIL: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 611 BRAZIL: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 612 BRAZIL: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 613 BRAZIL: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 614 BRAZIL: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 615 BRAZIL: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 616 BRAZIL: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 617 BRAZIL: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 618 BRAZIL: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 619 BRAZIL: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 620 BRAZIL: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 621 BRAZIL: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 622 BRAZIL: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 623 BRAZIL: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 624 MEXICO: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 625 MEXICO: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 626 MEXICO: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 627 MEXICO: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 628 MEXICO: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 629 MEXICO: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 630 MEXICO: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 631 MEXICO: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 632 MEXICO: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 633 MEXICO: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 634 MEXICO: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 635 MEXICO: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 636 MEXICO: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 637 MEXICO: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 638 MEXICO: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 639 MEXICO: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 640 MEXICO: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 641 MEXICO: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 642 MEXICO: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 643 MEXICO: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 644 MEXICO: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 645 MEXICO: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 646 MEXICO: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 647 ARGENTINA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 648 ARGENTINA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 649 ARGENTINA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 650 ARGENTINA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 651 ARGENTINA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 652 ARGENTINA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 653 ARGENTINA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 654 ARGENTINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 655 ARGENTINA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 656 ARGENTINA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 657 ARGENTINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 658 ARGENTINA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 659 ARGENTINA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 660 ARGENTINA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 661 ARGENTINA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 662 ARGENTINA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 663 ARGENTINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 664 ARGENTINA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 665 ARGENTINA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 666 ARGENTINA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 667 ARGENTINA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 668 ARGENTINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 669 ARGENTINA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 670 REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 671 REST OF LATIN AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 672 REST OF LATIN AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 673 REST OF LATIN AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 674 REST OF LATIN AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 675 REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 676 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 677 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 678 REST OF LATIN AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 679 REST OF LATIN AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 680 REST OF LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 681 REST OF LATIN AMERICA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 682 REST OF LATIN AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 683 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 684 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 685 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 686 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 687 REST OF LATIN AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 688 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 689 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 690 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 691 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 692 REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 693 MIDDLE EAST: BIOMATERIALS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 694 MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 695 MIDDLE EAST: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 696 MIDDLE EAST: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 697 MIDDLE EAST: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 698 MIDDLE EAST: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 699 MIDDLE EAST: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 700 MIDDLE EAST: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 701 MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 702 MIDDLE EAST: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 703 MIDDLE EAST: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 704 MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 705 MIDDLE EAST: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 706 MIDDLE EAST: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 707 MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 708 MIDDLE EAST: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 709 MIDDLE EAST: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 710 MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 711 MIDDLE EAST: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 712 MIDDLE EAST: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 713 MIDDLE EAST: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 714 MIDDLE EAST: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 715 MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 716 MIDDLE EAST: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 717 GCC COUNTRIES: BIOMATERIALS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 718 GCC COUNTRIES: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 719 GCC COUNTRIES: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 720 GCC COUNTRIES: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 721 GCC COUNTRIES: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 722 GCC COUNTRIES: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 723 GCC COUNTRIES: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 724 GCC COUNTRIES: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 725 GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 726 GCC COUNTRIES: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 727 GCC COUNTRIES: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 728 GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 729 GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 730 GCC COUNTRIES: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 731 GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 732 GCC COUNTRIES: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 733 GCC COUNTRIES: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 734 GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 735 GCC COUNTRIES: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 736 GCC COUNTRIES: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 737 GCC COUNTRIES: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 738 GCC COUNTRIES: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 739 GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 740 GCC COUNTRIES: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 741 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 742 KINGDOM OF SAUDI ARABIA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 743 KINGDOM OF SAUDI ARABIA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 744 KINGDOM OF SAUDI ARABIA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 745 KINGDOM OF SAUDI ARABIA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 746 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 747 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 748 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 749 KINGDOM OF SAUDI ARABIA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 750 KINGDOM OF SAUDI ARABIA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 751 KINGDOM OF SAUDI ARABIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 752 KINGDOM OF SAUDI ARABIA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 753 KINGDOM OF SAUDI ARABIA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 754 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 755 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 756 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 757 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 758 KINGDOM OF SAUDI ARABIA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 759 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 760 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 761 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 762 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 763 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 764 UAE: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 765 UAE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 766 UAE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 767 UAE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 768 UAE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 769 UAE: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 770 UAE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 771 UAE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 772 UAE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 773 UAE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 774 UAE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 775 UAE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 776 UAE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 777 UAE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 778 UAE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 779 UAE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 780 UAE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 781 UAE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 782 UAE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 783 UAE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 784 UAE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 785 UAE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 786 UAE: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 787 REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 788 REST OF GCC COUNTRIES: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 789 REST OF GCC COUNTRIES: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 790 REST OF GCC COUNTRIES: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 791 REST OF GCC COUNTRIES: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 792 REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 793 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 794 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 795 REST OF GCC COUNTRIES: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 796 REST OF GCC COUNTRIES: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 797 REST OF GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 798 REST OF GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 799 REST OF GCC COUNTRIES: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 800 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 801 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 802 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 803 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 804 REST OF GCC COUNTRIES: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 805 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 806 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 807 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 808 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 809 REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 810 REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 811 REST OF MIDDLE EAST: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 812 REST OF MIDDLE EAST: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 813 REST OF MIDDLE EAST: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 814 REST OF MIDDLE EAST: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 815 REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 816 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 817 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 818 REST OF MIDDLE EAST: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 819 REST OF MIDDLE EAST: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 820 REST OF MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 821 REST OF MIDDLE EAST: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 822 REST OF MIDDLE EAST: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 823 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 824 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 825 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 826 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 827 REST OF MIDDLE EAST: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 828 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 829 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 830 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 831 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 832 REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 833 AFRICA: BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 834 AFRICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 835 AFRICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 836 AFRICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 837 AFRICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 838 AFRICA: BIOMATERIALS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 839 AFRICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 840 AFRICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 841 AFRICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 842 AFRICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 843 AFRICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 844 AFRICA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 845 AFRICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 846 AFRICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 847 AFRICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 848 AFRICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 849 AFRICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 850 AFRICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 851 AFRICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 852 AFRICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 853 AFRICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 854 AFRICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 855 AFRICA: BIOMATERIALS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 856 STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET, JANAURY 2023-FEBRUARY 2026
TABLE 857 BIOMATERIALS MARKET: DEGREE OF COMPETITION
TABLE 858 BIOMATERIALS MARKET: REGION FOOTPRINT
TABLE 859 BIOMATERIALS MARKET: TYPE FOOTPRINT
TABLE 860 BIOMATERIALS MARKET: APPLICATION FOOTPRINT
TABLE 861 LIST OF KEY STARTUPS/SME PLAYERS IN BIOMATERIALS MARKET
TABLE 862 BIOMATERIALS: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE AND REGION
TABLE 863 BIOMATERIALS MARKET: PRODUCT LAUNCHES, JANUARY 2023-FEBRUARY 2026
TABLE 864 BIOMATERIALS MARKET: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 865 BIOMATERIALS MARKET: EXPANSIONS, JANUARY 2023-FEBRUARY 2026
TABLE 866 BASF SE: COMPANY OVERVIEW
TABLE 867 BASF SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 868 BASF SE: DEALS, JANUARY 2023-FEBRUARY 2026
TABLE 869 BASF SE: OTHER DEVELOPMENTS, JANUARY 2023-FEBRUARY 2026
TABLE 870 COVESTRO AG: COMPANY OVERVIEW
TABLE 871 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 872 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2023-FEBRUARY 2026
TABLE 873 COVESTRO AG: DEALS, JANUARY 2023-FEBRUARY 2026
TABLE 874 COVESTRO AG: EXPANSIONS, JANUARY 2023-FEBRUARY 2026
TABLE 875 COVESTRO AG: OTHER DEVELOPMENTS, JANUARY 2023-FEBRUARY 2026
TABLE 876 CELANESE CORPORATION: COMPANY OVERVIEW
TABLE 877 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 878 CELANESE CORPORATION: DEALS, JANUARY 2023-FEBRUARY 2026
TABLE 879 CARPENTER TECHNOLOGY CORPORATION: COMPANY OVERVIEW
TABLE 880 CARPENTER TECHNOLOGY CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 881 CARPPENTER TECHNOLOGY CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-FEBRUARY 2026
TABLE 882 EVONIK INDUSTRIES AG: COMPANY OVERVIEW
TABLE 883 EVONIK INDUSTRIES AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 884 EVONIK INDUSTRIES AG: PRODUCT LAUNCHES, JANUARY 2023-FEBRUARY 2026
TABLE 885 EVONIK INDUSTRIES AG: DEALS, JANUARY 2023-FEBRUARY 2026
TABLE 886 DSM: COMPANY OVERVIEW
TABLE 887 DSM: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 888 DSM: DEALS, JANUARY 2023-FEBRUARY 2026
TABLE 889 DSM: EXPANSIONS, JANUARY 2023-FEBRUARY 2026
TABLE 890 CORBION NV: COMPANY OVERVIEW
TABLE 891 CORBION NV: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 892 CORBION NV: EXPANSIONS, JANUARY 2023-FEBRUARY 2026
TABLE 893 VICTREX PLC: COMPANY OVERVIEW
TABLE 894 VICTREX PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 895 VICTREX PLC: PRODUCT LAUNCHES, JANUARY 2023-FEBRUARY 2026
TABLE 896 VICTREX PLC: EXPANSIONS, JANUARY 2023-FEBRUARY 2026
TABLE 897 MITSUBISHI CHEMICAL CORPORATION: COMPANY OVERVIEW
TABLE 898 MITSUBISHI CHEMICAL CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 899 COORSTEK INC.: COMPANY OVERVIEW
TABLE 900 COORSTEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 901 BERKELEY ADVANCED BIOMATERIALS: COMPANY OVERVIEW
TABLE 902 BERKELEY ADVANCED BIOMATERIALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 903 CAM BIOCERAMICS B.V.: COMPANY OVERVIEW
TABLE 904 CAM BIOCERAMICS B.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 905 CAM BIOCERAMICS B.V.: DEALS, JANUARY 2023-FEBRUARY 2026
TABLE 906 ZEUS COMPANY INC.: COMPANY OVERVIEW
TABLE 907 ZEUS COMPANY INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 908 ZEUS COMPANY INC.: PRODUCT LAUNCHES, JANUARY 2023-FEBRUARY 2026
TABLE 909 ZEUS COMPANY INC.: EXPANSIONS, JANUARY 2023-FEBRUARY 2026
TABLE 910 AMETEK.INC.: COMPANY OVERVIEW
TABLE 911 AMETEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 912 AMETEK INC.: DEALS, JANUARY 2023-FEBRUARY 2026
TABLE 913 AMETEK.INC.: EXPANSIONS, JANUARY 2023-FEBRUARY 2026
TABLE 914 GELITA AG: COMPANY OVERVIEW
TABLE 915 GELITA AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 916 GELITA AG.: PRODUCT LAUNCHES, JANUARY 2023-FEBRUARY 2026
TABLE 917 COLLAGEN SOLUTIONS (US) LLC: COMPANY OVERVIEW
TABLE 918 BIOCOMPOSITES: COMPANY OVERVIEW
TABLE 919 NOBLE BIOMATERIALS, INC.: COMPANY OVERVIEW
TABLE 920 REGENITY: COMPANY OVERVIEW
TABLE 921 KURARAY CO., LTD.: COMPANY OVERVIEW
TABLE 922 SOLESIS: COMPANY OVERVIEW
TABLE 923 INSTITUT STRAUMANN AG: COMPANY OVERVIEW
TABLE 924 FOSTER CORPORATION: COMPANY OVERVIEW
TABLE 925 CDI PRODUCTS: COMPANY OVERVIEW
TABLE 926 REVBIO, INC.: COMPANY OVERVIEW
TABLE 927 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS IN BIOMATERIALS MARKET
TABLE 928 BIOMATERIALS MARKET: RISK ANALYSIS

List of Figures

FIGURE 1 BIOMATERIALS MARKET SEGMENTATION
FIGURE 2 BIOMATERIALS MARKET: REGIONAL SCOPE
FIGURE 3 BIOMATERIALS MARKET: YEARS CONSIDERED
FIGURE 4 BIOMATERIALS MARKET SCENARIO
FIGURE 5 GLOBAL BIOMATERIALS MARKET SIZE, 2024-2031 (USD MILLION)
FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET, 2023-2026
FIGURE 7 DISRUPTIONS INFLUENCING BIOMATERIALS MARKET GROWTH
FIGURE 8 HIGH-GROWTH SEGMENTS IN BIOMATERIALS MARKET, BY TYPE, APPLICATION, END USER, AND REGION (2026-2031)
FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN BIOMATERIALS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 10 RISING ADVANCEMENTS IN SMART, BIOCOMPATIBLE, AND 3D PRINTED BIOMATERIALS TO DRIVE MARKET
FIGURE 11 US AND METALLIC BIOMATERIALS ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 12 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
FIGURE 13 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 BIOMATERIALS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 15 BIOMATERIALS MARKET: VALUE CHAIN ANALYSIS
FIGURE 16 BIOMATERIALS MARKET ECOSYSTEM ANALYSIS
FIGURE 17 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD)
FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS IN BIOMATERIALS MARKET
FIGURE 19 FUNDING AND NUMBER OF DEALS IN BIOMATERIALS MARKET, 2025 (USD MILLION)
FIGURE 20 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015-2025
FIGURE 21 IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET
FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE
FIGURE 23 KEY BUYING CRITERIA, BY END USER
FIGURE 24 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
FIGURE 25 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN BIOMATERIALS MARKET, 2023-2025 (USD MILLION)
FIGURE 27 BIOMATERIALS MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
FIGURE 28 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 29 BIOMATERIALS MARKET: COMPANY FOOTPRINT
FIGURE 30 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 31 EV/EBITDA OF KEY VENDORS
FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 33 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TYPE, IN BIOMATERIALS MARKET
FIGURE 34 BASF SE: COMPANY SNAPSHOT
FIGURE 35 COVESTRO AG: COMPANY SNAPSHOT
FIGURE 36 CELANESE CORPORATION: COMPANY SNAPSHOT
FIGURE 37 CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
FIGURE 38 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
FIGURE 39 DSM: COMPANY SNAPSHOT
FIGURE 40 CORBION NV: COMPANY SNAPSHOT
FIGURE 41 VICTREX PLC: COMPANY SNAPSHOT
FIGURE 42 MITSUBISHI CHEMICAL CORPORATION: COMPANY SNAPSHOT
FIGURE 43 AMETEK.INC.: COMPANY SNAPSHOT
FIGURE 44 BIOMATERIALS MARKET: RESEARCH DESIGN
FIGURE 45 BIOMATERIALS MARKET: BREAKDOWN OF DEMAND- AND SUPPLY-SIDE PRIMARIES
FIGURE 46 BIOMATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
FIGURE 47 BIOMATERIALS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2025
FIGURE 48 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF COVESTRO AG (2025)
FIGURE 49 BIOMATERIALS MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 50 BIOMATERIALS MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 51 BIOMATERIALS MARKET: CAGR PROJECTIONS
FIGURE 52 DATA TRIANGULATION METHODOLOGY IN BIOMATERIALS MARKET

Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030

Description

Table of Contents

List of Tables

The primary interviews conducted for this report can be categorized as follows:

List of Key Companies Profiled in the Report:

Research Coverage:

Key Benefits of Buying the Report:

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

4 MARKET OVERVIEW

5 INDUSTRY TRENDS

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

9 BIOMATERIALS MARKET, BY TYPE

10 BIOMATERIALS MARKET, BY APPLICATION

11 BIOMATERIALS MARKET, BY END USER

12 BIOMATERIALS MARKET, BY REGION

13 COMPETITIVE LANDSCAPE

14 COMPANY PROFILES

15 RESEARCH METHODOLOGY

16 APPENDIX

List of Tables

List of Figures